Comprehensive molecular comparison of hypermethylated and mutated triple negative breast cancers

Journal: Nature Communications

Published: 2020-07-27

DOI: 10.1038/s41467-020-17537-2

Affiliations: 11

Authors: 23

Go to article
Institutions Share
Division of Oncology and Pathology, LU, Sweden 0.60
Skåne University Hospital in Lund, SUS, Sweden 0.09
Division of Surgery, LU, Sweden 0.07
Department of Oncology-Pathology, KI, Sweden 0.04
Division of Translational Cancer Research, LU, Sweden 0.04
Department of Laboratory Medicine, LU, Sweden 0.04
Academic Department of Medical Genetics, University of Cambridge, United Kingdom (UK) 0.04
Division of Molecular Hematology (DMH), LU, Sweden 0.02
Division of Clinical Genetics, LU, Sweden 0.02
Wellcome Trust Genome Campus, United Kingdom (UK) 0.01
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER